Nektar Therapeutics (LON:0UNL)
0.8357
+0.0053 (0.64%)
At close: Jan 31, 2025
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
1.11M GBP
Profits / Employee
-1.69M GBP
Market Cap
90.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Nektar Therapeutics News
- 18 days ago - Nektar therapeutics outlines REZOLVE-AD phase 2b data and financial position for Q2 2025 - Seeking Alpha
- 18 days ago - Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Nektar Therapeutics Reports First Quarter 2025 Financial Results - Benzinga
- 18 days ago - Nektar Therapeutics Reports First Quarter 2025 Financial Results - PRNewsWire
- 20 days ago - Nektar Therapeutics's Earnings: A Preview - Benzinga
- 25 days ago - Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire
- 6 weeks ago - Nektar Therapeutics (NKTR) Shares Surge on Jefferies Upgrade - GuruFocus
- 2 months ago - Nektar Therapeutics files $300M mixed securities shelf - Seeking Alpha